Public Health awaiting peer review of study
The Isle of Man will not change its vaccination programme despite concerns about the South African variant of Covid-19.
It’s after reports suggest the Oxford-AstraZeneca vaccine may only offer limited protection from a mild to moderate strain of the new variant.
Public Health says the study – which only had 2,000 participants with an average age of 31 - still requires peer review.
Until that happens it says the current position is that the jab does protect against the predominant Covid variants currently circulating so there is ‘no reason to change’.
Amendments to Assisted Dying Bill approved by Tynwald
Last chance to submit nominations for local authority by-elections
Rapid review into hospital provides 'clear direction' but there is 'no single solution', says minister
UK farmer to host 'soil safari'
TT 2026: 'A sustained and demanding’ period for health service